Dexcom on Tuesday announced an artificial intelligence feature for its Stelo continuous glucose monitor that gives users a personalized look into how meals, sleep and activity impact their glucose levels. It’s the first iteration of a new generative AI platform that the company has been building with Google Cloud.
Stelo is an over-the-counter CGM that pokes through the skin to measure real-time blood sugar levels. The sensor launched in August and can be used by any adult who doesn’t take insulin.
The report reflects Dexcom’s effort to make Stelo more personalized and engaging for consumers as it works to penetrate a new market.
“The No. 1 feedback we get is users want to see more,” Jake Leach, chief operating officer at Dexcom, told CNBC in an interview. “They’re making an investment and wearing the product, and they want to be able to take the most advantage of all the data that they’re generating.”
Dexcom is using Google’s Gemini models and its Vertex AI platform as the foundation for its new AI offering. Vertex AI allows developers to build applications that synthesize different types of data, which can be notoriously challenging in health care.
Leach said Dexcom is also exploring how its generative AI platform can be used across its other CGM products, but the company is proceeding extra carefully since patients rely on them to prevent medical emergencies.
“It really felt like Stelo was the right place to do this for the first time,” he said.
An existing insights report has already been available to users within the Stelo app, but it followed a more standard template format each week. Dexcom believes the AI-generated report will be more valuable to users since it’s personalized, Leach said.
If there’s a week where a user is not moving enough after meals, for instance, the report would include relevant tips and educational materials to help.
Stelo’s AI reports don’t give users medical advice, though Dexcom has been using an AI framework from the U.S. Food and Drug Administration to help guide the feature’s development, Leach said. The FDA approved Stelo in March.
Eventually, Dexcom wants to use its generative AI platform to deliver real-time feedback to users instead of just weekly reports. The company is also exploring how the technology could act as a predictive indicator for potential problems, much like a check engine light on a car.
“It gives you a sense for what could be going on, and recommendations of where you might want to go to seek more advice,” Chris Sakalosky, vice president of strategic industries for Google Cloud, told CNBC in an interview.
Dexcom’s updated weekly report began rolling out to Stelo users this week.
The logo of Japanese company SoftBank Group is seen outside the company’s headquarters in Tokyo on January 22, 2025.
Kazuhiro Nogi | Afp | Getty Images
Shares of SoftBank Group plunged as much as 9.17% Wednesday, as technology stocks in Asia declined, tracking losses in U.S. peers overnight.
The Japanese tech-focused investment firm saw shares drop for a second consecutive session, following its announcement of a $2 billion investment in Intel. Intel shares rose 6.97% to close at $25.31 Tuesday stateside.
Stock Chart IconStock chart icon
SoftBank Group shares
Other Japanese tech stocks also declined, with semiconductor giant Advantest falling as much as 6.27%. Meanwhile, shares in Renesas Electronics and Tokyo Electron were last seen trading 2.46% and 0.75% lower, respectively.
Technology companies in South Korea, Taiwan and Hong Kong, also fell after U.S. tech stocks dropped overnight spurred by declines in artificial intelligence darling Nvidia‘s shares.
U.S. Commerce Secretary Howard Lutnick is considering the federal government taking equity stakes in semiconductor companies that get funding under the CHIPS Act for building plants in the U.S, sources familiar with the matter told Reuters. The U.S. CHIPS and Science Act seeks to boost the country’s semiconductor industry, scientific research and innovation.
Shares of Taiwanese chip company TSMC and manufacturer Hon Hai Precision Industry — known globally as Foxconn — declined 1.69% and 2.16%, respectively. TSMC manufactures Nvidia’s high-performance graphics processing units that help power large language models, while Foxconn has a strategic partnership with Nvidia to build “AI factories.”
Meanwhile, South Korean tech stocks mostly fell with shares of chipmaker SK Hynix down 3.33%. Samsung Electronics, however, rose 0.75%.
TSMC, Samsung and SK Hynix are among companies that have received funding under the CHIPS Act.
Over in Hong Kong, the Hang Seng Tech index lost 0.87% in early trade.
CEO of Palantir Technologies Alex Karp attends the Pennsylvania Energy and Innovation Summit on the campus of Carnegie Mellon University in Pittsburgh, Pennsylvania on July 15, 2025.
Andrew Caballero-reynolds | Afp | Getty Images
Palantir‘s stock slumped more than 9% on Tuesday, falling for a fifth straight day to continue its pullback from all-time highs.
The artificial intelligence software provider’s stock has slid more than 15% over the last five trading sessions, after a stellar earnings report earlier this month propelled shares to all-time highs. The report was Palantir’s first-ever $1 billion revenue quarter.
Tuesday’s dip coincided with a broader market pullback.
Palantir is the most significant gainer to date in the S&P 500 in 2025, up more than 100%.
Read more CNBC tech news
Shares have more than doubled as the company benefits from ongoing AI enthusiasm, scooping up government contracts with President Donald Trump pushing to overhaul agencies.
Palantir’s ascent has pushed the company into a list of top 10 U.S. tech firms and 20 most valuable U.S. companies, while also making shares incredibly expensive to own. Its forward price-to-earnings ratio, which tracks future earnings relative to share price, has soared past 245 times.
By comparison, technology giants such as Microsoft and Apple carry a P/E of nearly 30 times and rake in significantly greater quarterly revenues. Meta‘s and Alphabet‘s P/E ratios hover in the 20s.
The data analytics software vendor said Tuesday that it’s raising a funding round that values the company at over $100 billion. That would make Databricks just the fourth private company to eclipse the $100 billion mark, following SpaceX, ByteDance and OpenAI, according to data from CB Insights.
Databricks CEO Ali Ghodsi told CNBC’s Brian Sullivan that the total round will exceed $1 billion. The company was last valued by private investors at $62 billion in a $10 billion financing round late last year.
In June, Databricks executives told investors the company was forecasting $3.7 billion in annualized revenue by July, with 50% year-over-year growth.
Snowflake, one of Databricks’ top rivals, is expected to generate $4.5 billion in revenue for the fiscal year that ends in January, representing annual growth of 25%, according to LSEG. Snowflake currently has a market cap of about $65 billion. Other competitors include cloud providers such as Amazon and Microsoft, which are also Databricks partners.
Ghodsi said he heard from a lot of interested investors following Figma’s IPO late last month. Shares of the design software company more than tripled in their New York Stock Exchange debut, a sign that public investors are seeking out tech offerings after in extended lull in the IPO market.
“My phone was blowing up,” Ghodsi said on Tuesday. “So yes, there’s definitely been a big push from outside.”
Figma shares have since retreated from their initial $115.50 closing price. The stock is trading at about $70, still more than double the $33 IPO price.
Ghodsi said the round will help Databricks invest in products that clients can tap when using artificial intelligence models.
Founded in 2013 and based in San Francisco, Databricks ranked third on CNBC’s 2025 Disruptor 50 list. As of June, the company employed 8,000 people. Existing investors Andreessen Horowitz, Insight Partners Thrive Capital and WCM Investment Management are buying shares, a spokesperson said.